Chuck Smith, M.D., Ph.D.
About Chuck Smith, M.D., Ph.D.
Chuck Smith, M.D., Ph.D., serves as the Vice President of Patient Safety at Kite Pharma, bringing over two decades of experience in clinical development, particularly in oncology and immunology. He has a strong background in managing clinical trials and has held various leadership positions in notable organizations, including Novartis and Cambridge Antibody Technology.
Work at Kite Pharma
Chuck Smith, M.D., Ph.D. serves as the Vice President of Patient Safety at Kite Pharma since 2021. In this role, he oversees patient safety protocols and ensures compliance with regulatory standards. Kite Pharma specializes in innovative cancer therapies, particularly in the field of cell therapy. Smith's extensive background in oncology and clinical development contributes to the company's commitment to patient safety and effective treatment outcomes.
Education and Expertise
Chuck Smith studied at the State University of New York Downstate Health Sciences University. He possesses expertise in oncology, immunology, adult medicine, and antibodies. His educational background and professional experience equip him with the knowledge necessary to lead clinical trials and patient safety initiatives effectively.
Background
Chuck Smith has over two decades of experience in clinical development processes for biologics and small molecules. He has held various leadership positions in notable organizations, including Novartis, Cambridge Antibody Technology, Genencor International, Inc., and Innomab, Inc. His career has been marked by a focus on translational research and the management of clinical trials from late research stages to phase two studies.
Achievements
Throughout his career, Chuck Smith has successfully delivered clinical trials on time and within budget. He has experience in obtaining and integrating key opinion leader input, which is essential for assessing candidate molecules for in-licensing or investment. His leadership roles have included building and reorganizing clinical development organizations, both in-house and virtual.
Personal Health Journey
Chuck Smith was diagnosed with follicular lymphoma, which prompted him to consult with an oncologist regarding treatment options. After undergoing multiple rounds of chemotherapy, his cancer went into remission but later returned. His personal health journey has influenced his perspective on patient care and treatment options, further motivating his work in the oncology field.